Repurposing the Whole Expression Transcriptome Assay for the Genetic Diagnosis of T-Cell Acute Lymphoblastic Leukemia and Lymphoma

Unlike other cases of acute leukemia, the diagnosis of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is uniquely based on morphology and flow cytometry. Although the genomic background has been broadly uncovered, the large spectrum of genes involved and the variability of the molecular me...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Journal of molecular diagnostics : JMD Ročník 27; číslo 5; s. 360
Hlavní autoři:	Bardelli, Valentina, Arniani, Silvia, Pierini, Valentina, Nardelli, Carlotta, Matteucci, Caterina, Lema Fernandez, Anair Graciela, Crocioni, Maria, Cerrano, Marco, Salutari, Prassede, Papayanidis, Cristina, Trappolini, Silvia, Giglio, Fabio, Mastaglio, Sara, Zappasodi, Patrizia, Pasciolla, Crescenza, Defina, Marzia, Piccini, Matteo, Lanzarone, Giuseppe, Di Giacomo, Danika, Sica, Simona, Montefiori, Lindsey E, Mullighan, Charles G, Mecucci, Cristina, La Starza, Roberta
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.05.2025
Témata:	Gene Expression Profiling - methods Humans Mutation Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics Transcriptome
ISSN:	1943-7811, 1943-7811
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Unlike other cases of acute leukemia, the diagnosis of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is uniquely based on morphology and flow cytometry. Although the genomic background has been broadly uncovered, the large spectrum of genes involved and the variability of the molecular mechanisms underlying gene deregulation have delayed the introduction of molecular cytogenetics into diagnostic flowcharts. To overcome these limitations and implement a genetic diagnosis of T-ALL/LBLs, a whole transcriptome expression assay (WTEa) was repurposed as a "priority test" to classify T-ALL/LBLs into the major genetic subtypes. A WTEa classifier based on a set of 312 probes on 215 T-ALL/LBLs was set up and applied, which properly assigned >95% of cases with subtype-defining alterations to the corresponding subgroups (ie, TAL/LMO, HOXA, TLX1, TLX3, BCL11B). It pinpointed cases that harbored cryptic alterations, such as noncoding mutations that generate new enhancer at TAL1 and LMO2 loci (8% of TAL/LMO), and duplications of noncoding element downstream BCL11B (BETA) (18% of BCL11B). It was also suitable to classify lymphoma cases for which only formalin-fixed embedded tissues were available, as confirmed in cases harboring TLX1 or TLX3 rearrangements, and distinguished new putative subtypes. WTEa offers a unifying tool to provide a genetic classification of T-ALL/LBLs. If introduced in multicenter prospective studies, it will facilitate evaluation of the clinical impact of genetic classification.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1943-7811 1943-7811
DOI:	10.1016/j.jmoldx.2025.01.006